The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Naloxone drug in this report.
The global Naloxone market was valued at US$ 26800 million in 2023 and is anticipated to reach US$ 33840 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
North American market for Naloxone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Naloxone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Naloxone include ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Naloxone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naloxone.
Report Scope
The Naloxone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Naloxone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naloxone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ADAPT Pharma
Amphastar Pharmaceuticals
Pfizer
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Segment by Type
Spray Forms
Injectable Forms
Segment by Application
Drug Store
Hospital Pharmacies
Online
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naloxone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Naloxone drug in this report.
The global Naloxone market was valued at US$ 26800 million in 2023 and is anticipated to reach US$ 33840 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
North American market for Naloxone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Naloxone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Naloxone include ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Naloxone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naloxone.
Report Scope
The Naloxone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Naloxone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naloxone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ADAPT Pharma
Amphastar Pharmaceuticals
Pfizer
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Segment by Type
Spray Forms
Injectable Forms
Segment by Application
Drug Store
Hospital Pharmacies
Online
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naloxone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Naloxone Market Overview
1.1 Product Overview and Scope of Naloxone
1.2 Naloxone Segment by Type
1.2.1 Global Naloxone Market Value Comparison by Type (2024-2030)
1.2.2 Spray Forms
1.2.3 Injectable Forms
1.3 Naloxone Segment by Application
1.3.1 Global Naloxone Market Value by Application: (2024-2030)
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Global Naloxone Market Size Estimates and Forecasts
1.4.1 Global Naloxone Revenue 2019-2030
1.4.2 Global Naloxone Sales 2019-2030
1.4.3 Global Naloxone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Naloxone Market Competition by Manufacturers
2.1 Global Naloxone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Naloxone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Naloxone Average Price by Manufacturers (2019-2024)
2.4 Global Naloxone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Naloxone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Naloxone, Product Type & Application
2.7 Naloxone Market Competitive Situation and Trends
2.7.1 Naloxone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Naloxone Players Market Share by Revenue
2.7.3 Global Naloxone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Naloxone Retrospective Market Scenario by Region
3.1 Global Naloxone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Naloxone Global Naloxone Sales by Region: 2019-2030
3.2.1 Global Naloxone Sales by Region: 2019-2024
3.2.2 Global Naloxone Sales by Region: 2025-2030
3.3 Global Naloxone Global Naloxone Revenue by Region: 2019-2030
3.3.1 Global Naloxone Revenue by Region: 2019-2024
3.3.2 Global Naloxone Revenue by Region: 2025-2030
3.4 North America Naloxone Market Facts & Figures by Country
3.4.1 North America Naloxone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Naloxone Sales by Country (2019-2030)
3.4.3 North America Naloxone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Naloxone Market Facts & Figures by Country
3.5.1 Europe Naloxone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Naloxone Sales by Country (2019-2030)
3.5.3 Europe Naloxone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Naloxone Market Facts & Figures by Country
3.6.1 Asia Pacific Naloxone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Naloxone Sales by Country (2019-2030)
3.6.3 Asia Pacific Naloxone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Naloxone Market Facts & Figures by Country
3.7.1 Latin America Naloxone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Naloxone Sales by Country (2019-2030)
3.7.3 Latin America Naloxone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Naloxone Market Facts & Figures by Country
3.8.1 Middle East and Africa Naloxone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Naloxone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Naloxone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Naloxone Sales by Type (2019-2030)
4.1.1 Global Naloxone Sales by Type (2019-2024)
4.1.2 Global Naloxone Sales by Type (2025-2030)
4.1.3 Global Naloxone Sales Market Share by Type (2019-2030)
4.2 Global Naloxone Revenue by Type (2019-2030)
4.2.1 Global Naloxone Revenue by Type (2019-2024)
4.2.2 Global Naloxone Revenue by Type (2025-2030)
4.2.3 Global Naloxone Revenue Market Share by Type (2019-2030)
4.3 Global Naloxone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Naloxone Sales by Application (2019-2030)
5.1.1 Global Naloxone Sales by Application (2019-2024)
5.1.2 Global Naloxone Sales by Application (2025-2030)
5.1.3 Global Naloxone Sales Market Share by Application (2019-2030)
5.2 Global Naloxone Revenue by Application (2019-2030)
5.2.1 Global Naloxone Revenue by Application (2019-2024)
5.2.2 Global Naloxone Revenue by Application (2025-2030)
5.2.3 Global Naloxone Revenue Market Share by Application (2019-2030)
5.3 Global Naloxone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ADAPT Pharma
6.1.1 ADAPT Pharma Corporation Information
6.1.2 ADAPT Pharma Description and Business Overview
6.1.3 ADAPT Pharma Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ADAPT Pharma Naloxone Product Portfolio
6.1.5 ADAPT Pharma Recent Developments/Updates
6.2 Amphastar Pharmaceuticals
6.2.1 Amphastar Pharmaceuticals Corporation Information
6.2.2 Amphastar Pharmaceuticals Description and Business Overview
6.2.3 Amphastar Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amphastar Pharmaceuticals Naloxone Product Portfolio
6.2.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Naloxone Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Kaleo
6.4.1 Kaleo Corporation Information
6.4.2 Kaleo Description and Business Overview
6.4.3 Kaleo Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kaleo Naloxone Product Portfolio
6.4.5 Kaleo Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz Naloxone Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Amneal Pharmaceuticals
6.6.1 Amneal Pharmaceuticals Corporation Information
6.6.2 Amneal Pharmaceuticals Description and Business Overview
6.6.3 Amneal Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amneal Pharmaceuticals Naloxone Product Portfolio
6.6.5 Amneal Pharmaceuticals Recent Developments/Updates
6.7 West Ward Pharmaceuticals
6.6.1 West Ward Pharmaceuticals Corporation Information
6.6.2 West Ward Pharmaceuticals Description and Business Overview
6.6.3 West Ward Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 West Ward Pharmaceuticals Naloxone Product Portfolio
6.7.5 West Ward Pharmaceuticals Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Naloxone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Naloxone Product Portfolio
6.8.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Naloxone Industry Chain Analysis
7.2 Naloxone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Naloxone Production Mode & Process
7.4 Naloxone Sales and Marketing
7.4.1 Naloxone Sales Channels
7.4.2 Naloxone Distributors
7.5 Naloxone Customers
8 Naloxone Market Dynamics
8.1 Naloxone Industry Trends
8.2 Naloxone Market Drivers
8.3 Naloxone Market Challenges
8.4 Naloxone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
